Flash
›
Moderna, Inc. (MRNA) Deep Dive Video
Moderna, Inc. (MRNA) Deep Dive Video
Summary
Moderna’s mRNA platform and oncology pipeline offer meaningful upside optionality, but at $200.10 the stock prices in clinical success despite persistent losses, cash burn, and a probability-weighted five-year value of $92.15.
View MRNA stock page
·
Read the MRNA research report
Loading the video player…
Loading Flash…